An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical practice, according to a study published in the journal Oncology Reports.
Molecular oncologist Fumihiro Higashino and colleagues deleted a gene involved in viral replication, called E4orf6, from a type of adenovirus. The team previously discovered that E4orf6 stabilizes a type of mRNA called ARE-mRNAs in the infected cells enabling viral replication. ARE-mRNAs are known to be stable in stressed cells and cancer cells, but rapidly degrade in normal cells.
In laboratory tests, they found that their modified adenovirus, called dl355, replicated and increased its number significantly more in cancer cells than it did in normal cells. Higashino explains “The E4orf6-lacking virus relies on the stable ARE-mRNAs in cancer cells for its replication.”
Some viruses can be used to treat cancers, as they replicate within the cells until they burst and die. The researchers infected several types of cultured cancer cells with 100 dl355 virus particles per cell and found that nearly all the cancer cells died within seven days. In contrast, most normal cells infected with the virus did not die, even after seven days. Several cancer cell lines managed to survive low doses of dl355, but all cancer cells were killed by the virus as the dose was increased. Tumour growth was also significantly suppressed when dl355 was administered to human tumour cells grown in mice.
Finally, the team compared the anticancer effects of dl355 with another anticancer adenovirus currently used in clinical practice, called dl1520. dl355 replication was higher in all cancer cell lines tested, including cervical and lung cancer cells, and was better at killing all but one type of cancer cell, compared to dl1520. Both viruses only killed very few normal cells.
The findings suggest that dl355 has potential to be an effective anticancer treatment, the team concludes. They suggest enhancing the stabilization of ARE-mRNAs in cancer cells could even further strengthen its effect, but Professor Higashino notes that further research is required. “While we think dl355 has the potential to be an effective treatment method in dealing with many types of cancers, much more research needs to be done. When we think of a timeline, at least five more years of further research may be required, possible more, on top of clinical trials,” Professor Higashino noted.
Learn more: Engineering a cancer-fighting virus
The Latest on: Engineered virus
via Google News
The Latest on: Engineered virus
- Oncolytic Virus Immunotherapy Market Is Anticipated to Expand at a Steady Pace Due to Rise in the Number of Cancer Cases Across the Globe on February 12, 2019 at 1:30 am
The first US FDA approved oncolytic herpes virus (a modified herpes simplex virus) is the drug talimogene laherparepvec (OncoVex, T-VEC), approved in 2015, for the treatment of advanced inoperable mel... […]
- Good Guy Malware: Linux Virus Removes Other Infections to Mine on Its Own on February 12, 2019 at 12:09 am
The script that the malware uses for spreading downloads a modified version of XMR-Stak ... resources Trend Micro explains that the virus targets systems via IP cameras and web services on ... […]
- Protection Against Mosquito-borne Mayaro Virus Using Engineered DNA Vaccine on February 9, 2019 at 10:27 am
A new vaccine capable of inducing protective immunity against mosquito-borne Mayaro virus (MAYV) has been developed by scientists. The findings are reported in PLOS Neglected Tropical Diseases. Infect... […]
- Engineered DNA Vaccine Protects Against Emerging Mayaro Virus Infection on February 8, 2019 at 8:18 am
A novel, synthetic DNA vaccine developed at the Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to ... […]
- Engineered DNA vaccine protects against emerging Mayaro virus on February 7, 2019 at 11:04 am
Infections by the mosquito-borne Mayaro virus (MAYV) have largely been restricted to people who ventured into the heavily forested areas of Trinidad and Tobago and neighboring regions of South ... […]
- Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus on February 7, 2019 at 2:29 am
Virus-like particles (VLPs) possess great potential for organ-specific transport of therapeutic agents due to their central cavity surrounded by viral capsid proteins and similar tropism to their orig... […]
- Red-eyed mosquitoes engineered to break the chain of Zika virus transmission on February 6, 2019 at 9:53 pm
Scientists in Australia are looking at some pretty creative ways to tackle the Zika virus, which continues to pose a risk to millions across Africa, Asia and parts of the Americas. Following a ... […]
- Potential treatment for eye cancer using tumor-killing virus on February 6, 2019 at 3:35 am
Now, in a recent report published in Science Translational Medicine, scientists have found another approach to target retinoblastoma using safer: cancer-killing viruses. The researchers then an... […]
- The Conversation: Hemant Khanna on potential treatment for eye cancer using tumor-killing virus on February 5, 2019 at 10:34 am
In my lab we are exploring using modified viruses as vehicles to deliver the correct form of a gene into the diseased cells of the eye. The newly published study describes what I believe is a game-cha... […]
- Engineered virus can destroy cancer: study on February 4, 2019 at 10:26 pm
Researchers have engineered a virus that selectively targets and kills cancer cells. The virus, a type of adenovirus (a group of viruses that cause respiratory illnesses), known as dl355 has a stronge... […]
via Bing News